Pulmonx Corp

NASDAQ:LUNG  
21.02
+1.66 (+8.57%)
Earnings Announcements

Pulmonx Q2 Revenue Rose 14 Percent To $14 Million

Published: 08/02/2022 21:20 GMT
Pulmonx Corp (LUNG) - Pulmonx Reports Second Quarter 2022 Financial Results.
Q2 Revenue Rose 14 Percent to $14 Million.
Net Loss in Q2 of 2022 Was $14.6 Million, Or $0.40 per Share.
Q2 Earnings per Share View $-0.41, Revenue View $13.7 Million -- Refinitiv Ibes Data (analyst estimates).
Revenue is expected to be $15 Million
Adjusted EPS is expected to be -$0.40

Next Quarter Revenue Guidance is expected to be $17.89 Million
Next Quarter EPS Guidance is expected to be -$0.40

More details on our Analysts Page.